Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Retained Earnings: 2022-2025

Historic Retained Earnings for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to -$65.4 million.

  • bioAffinity Technologies' Retained Earnings fell 29.03% to -$65.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.4 million, marking a year-over-year decrease of 29.03%. This contributed to the annual value of -$53.6 million for FY2024, which is 20.27% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Retained Earnings is -$65.4 million, which was down 8.31% from -$60.4 million recorded in Q2 2025.
  • bioAffinity Technologies' Retained Earnings' 5-year high stood at -$35.0 million during Q3 2022, with a 5-year trough of -$65.4 million in Q3 2025.
  • For the 3-year period, bioAffinity Technologies' Retained Earnings averaged around -$49.7 million, with its median value being -$48.7 million (2024).
  • Data for bioAffinity Technologies' Retained Earnings shows a maximum YoY dropped of 29.03% (in 2025) over the last 5 years.
  • Over the past 4 years, bioAffinity Technologies' Retained Earnings (Quarterly) stood at -$36.7 million in 2022, then fell by 21.65% to -$44.6 million in 2023, then fell by 20.27% to -$53.6 million in 2024, then fell by 29.03% to -$65.4 million in 2025.
  • Its last three reported values are -$65.4 million in Q3 2025, -$60.4 million for Q2 2025, and -$56.3 million during Q1 2025.